Skip to content

ADMA Biologics

US · ADMA #2705 by market cap Listed 1970
13.17 -0.17 -1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 0 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Cantor Fitzgerald moved from Buy to Hold on 2026-03-25.

Analyst consensus 3 analysts

Buy
Avg price target 16.67 +26.6%
Price target rangecurrent 13.17
Low13.00
Avg16.67
High19.00
Buy 67% Hold 33% Sell 0%
Recent ratings (15)
DateFirmAnalystRatingTarget
2026-11-05 Cantor Fitzgerald -- Hold 13.00
2026-11-05 CCORF -- Buy 19.00
2026-11-05 Mizuho Securities -- Buy 18.00
2026-08-06 CCORF -- Buy 18.00
2026-08-05 Cantor Fitzgerald -- Hold 12.00
2026-07-15 Mizuho Securities -- Buy 17.00
2026-06-14 CCORF -- Buy 18.00
2026-06-10 Raymond James -- Buy 21.00
2026-05-07 Mizuho Securities -- Buy 20.00
2026-05-05 CCORF -- Buy 18.00
2026-04-20 CCORF -- Buy 21.00
2026-04-13 Mizuho Securities -- Buy 24.00
2026-03-25 Cantor Fitzgerald -- Hold 30.00
2026-02-25 Cantor Fitzgerald -- Buy 30.00
2025-11-05 Cantor Fitzgerald -- Buy 30.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-03-25 Cantor Fitzgerald Buy → Hold 30.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±17.90% +26.05% (beat)
2026/Q2 2026-08-05 After close ±11.41% +8.64% (in line)
2026/Q1 2026-05-06 After close ±14.46% -15.97% (beat)
2025/Q4 2026-02-25 After close ±11.89% -3.19% (in line)
2025/Q3 2025-11-05 After close ±16.07% -8.72% (in line)
2025/Q2 2025-08-06 After close ±15.49% -9.65% (in line)
2025/Q1 2025-05-07 After close ±14.34% -10.21% (in line)
2024/Q4 2025-03-03 After close ±18.41% +7.45% (in line)
2024/Q3 2024-11-07 After close ±17.12% +14.71% (in line)
2024/Q2 2024-08-08 After close ±24.82% +30.93% (beat)
2024/Q1 2024-05-09 After close ±11.40% +27.13% (beat)
2023/Q4 2024-02-28 After close ±16.17% -0.37% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ADMA Biologics discussion 0 comments

Add a comment